聯通(00762.HK)夥中電信(00728.HK)共建共享5G網絡 開市初段各漲6%及4%
聯通(00762.HK)與中電信(00728.HK)進行5G網絡共建共享合作,消息刺激兩者今早股價造好,前者最新漲近6%報8.51元,暫為最強藍籌股,創約兩個月高位,成交1.86億元,後者彈近4%報3.72元,同樣創約兩個月高,暫為表現最佳國指成分股,成交4,044萬元。
中國聯通與中國電信簽署《5G網絡共建共享框架合作協議書》。據此,雙方在全國範圍內合作共建一張5G接入網絡,雙方將於15個城市,包括北京、天津、上海、深圳等劃分區域,各自負責在劃定區域建設5G網絡,同時共享接入網和5G頻率資源。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.